Drug alert number: EL (24)A/05
Date issued: 12 February 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited) PL 36687/0222
SNOMED Code: 36834211000001109
Batch Number
Expiry Date
Pack Size
First Distributed
MG21264
29/02/2024
28 tablets
13/12/2021
MG21334
31/03/2024
28 tablets
30/03/2022
MG21335
31/03/2024
28 tablets
26/05/2022
MG221014
30/11/2025
28 tablets
22/03/2023
MG221016
30/11/2025
28 tablets
16/05/2023
MG23488
30/04/2026
28 tablets
25/08/2023
MG23489
30/04/2026
28 tablets
12/09/2023
MG23490
30/04/2026
28 tablets
12/10/2023
MG23729
30/04/2026
28 tablets
05/12/2023
Active Pharmaceutical Ingredient: Ramipril
Brief description of the problem
Torrent Pharma (UK) Limited is recalling the above batches of Ramipril 1.25mg tablets as a precautionary measure due to these batches having a low assay and high related substances test results after their release to the market.
Advice for healthcare professionals
Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
Advice for patients
No further action is required by patients, these batches are being recalled at the pharmacy and wholesaler level as a precautionary measure. Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Further Information
For medical information enquiries please contact APCER Life Sciences, via telephone: 0800 0885366, or email: Medinfo.Torrent@apcerls.com
For stock control enquiries please contact the Torrent Pharma (UK) Limited Customer Service & Sales Executive via telephone: 01293 574188,or email: luke.davies@torrentpharma.co.uk or priti.pragji@torrentpharma.co.uk
The post MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited) appeared first on Community Pharmacy England.